Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGF Trap-Eye vs laser for diabetic macular edema (China, Phase 3)
CTR20131624Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of aflibercept in diabetic macular edema (DME), sponsored by Bayer. Started Jun 2014; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on CTR20131624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131624.